NOVO_B price outlook: Novo Nordisk holds above 1 (100%) support ARC. Potential rebound toward 306.00
Novo Nordisk A/S class B (NOVO_B): Arc Cycle analysis
Overview: Based on Arc Cycle Analysis applied to the 30m chart, Novo Nordisk is interacting with the 1 (100%) Support Arc within the current Arc Cycle. Price is holding above this Support Arc, suggesting the potential for a bullish rebound toward the next Resistance Arc.
Metric | Reading |
Market bias | Neutral-Bullish |
Preferred scenario | Potential Rebound |
Primary target zone | 306.00 |
Scenario invalidation | Sustained close below 294.00 |
Current arc level | Support Arc (1 / 100%) |
Cycle status | Testing Support Arc |
Arc integrity | Strong |
Market outlook
Price is holding above the 1 (100%) Support Arc, indicating that this Arc continues to provide support within the current Arc Cycle. If the Support Arc continues to hold, a rebound toward 306.00 price becomes the preferred scenario.
Conversely, a sustained 30m close below the Support Arc at 294.00 would invalidate the bullish scenario and shift the outlook toward the next lower Support Arc.

Author

Mohamad Gharib
Independent Analyst
Mohamad Gharib is a Financial Markets Analyst and Quantitative Researcher with more than 18 years of experience in financial markets, including 15 years as an FX Quant Trader.

















